logo

For the Inventor, By the Inventor

Escondido, CA, United States of America

Darrell R Anderson

This inventor holds 22 USPTO granted patents, primarily in Antibody Therapy. Top assignees: Biogen Idec, Inc., Idec Pharmaceuticals Corporation, Idec Pharmaceutical Corporation. Active years: 1998-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Darrell R Anderson. Retrieved from https://idiyas.com/inventor/darrell-r-anderson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 22

% Patents Active = 45.5

Average Co-Inventor Count = 4.0

ph-index = 11

Forward Citations = 1,639(Granted Patents)


Company Filing History:

goldMedal14 out of 46 
 
Biogen Idec, Inc.
 patents
silverMedal4 out of 37 
 
Idec Pharmaceuticals Corporation
 patents
bronzeMedal1 out of 3 
 
Idec Pharmaceutical Corporation
 patents
4. 3 out of 834,659 
Other
 patents

Years Active: 1998-2010

Loading Chart...
Areas of Expertise:
Anti-CD20 Antibodies
CD80-Specific Antibodies
B Cell Lymphoma
Immunosuppression
Rheumatoid Arthritis
Nucleic Acids
Chimeric Antibodies
Radiolabeled Antibodies
Intestinal Inflammation
Psoriasis
Human Antigens
22 patents (USPTO):Explore Patents
1. 7744877 - Expression and use of anti-CD20 Antibodies (2010-06-29),
2. 7510713 - Methods of inducing immunosuppression by administering 7C10 and 16C10 CD80-specific antibodies (2009-03-31),
3. 7510712 - Methods of treating rheumatoid arthritis with 7C10 and 16C10 CD80-specific antibodies (2009-03-31),
4. 7501264 - Methods of producing 7C10 and 16C10 CD80-specific antibodies (2009-03-10),
5. 7491393 - Methods of inhibiting IL-2 production by T cells by administering 7C10 and 16C10 CD80-specific antibodies (2009-02-17),
6. 7425447 - Host cells expressing 7C10 and 16C10 CD80-specific antibodies (2008-09-16),
7. 7422739 - Anti-CD20 antibodies (2008-09-09),
8. 7417128 - 7C10 and 16C10 CD80-specific antibodies (2008-08-26),
9. 7414123 - Nucleic acids encoding 7C10 and 16C10 CD80-specific antibodies (2008-08-19),
10. 7381560 - Expression and use of anti-CD20 antibodies (2008-06-03),
11. 7323170 - Anti-CD80 antibodies (2008-01-29),
12. 7192585 - CD80 specific antibodies (2007-03-20),
13. 7175847 - Treating intestinal inflammation with anti-CD80 antibodies that do not inhibit CD80 binding to CTLA-4 (2007-02-13),
14. 7153508 - Treatment of B cell lymphoma using anti-CD80 antibodies that do not inhibit the binding of CD80 to CTLA-4 (2006-12-26),
15. 6893638 - Methods for treating b cell lymphoma using CD80-specific antibodies (2005-05-17),

Title: Darrell R Anderson: Pioneering Inventor from Escondido

Introduction: Darrell R Anderson is a renowned inventor hailing from Escondido, California. With a passion for innovation and a keen eye for problem-solving, he has made significant contributions to various fields through his inventive spirit.

Latest Patents: Darrell R Anderson's latest patents showcase his expertise in developing cutting-edge solutions for everyday challenges. His recent inventions have focused on sustainability, technology, and healthcare, demonstrating his versatility as an inventor.

Career Highlights: Throughout his illustrious career, Darrell R Anderson has been recognized for his groundbreaking inventions that have had a lasting impact on society. His dedication to pushing the boundaries of innovation has led to numerous successful patents and accolades in the industry.

Collaborations: Darrell R Anderson has collaborated with leading experts in the field to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects, highlighting his strong collaborative spirit.

Conclusion: In conclusion, Darrell R Anderson's innovative mindset and passion for creating solutions have established him as a prominent figure in the world of inventions. His contributions continue to inspire future generations of inventors to think outside the box and pursue their creative ideas.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…